A Phase III extension trial for patients ages 6 months to 18 years of age who have previously participated in a clinical trial for dupilumab.
Dermira protocol DRM06-AD01: A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial To Evaluate The Efficacy And Safety Of Lebrikizumab In Patients With Moderate-To-Severe Atopic Dermatitis-ACTIVE/NOT ENROLLING
A Phase II clinical trial investigating a biologic IL-13 inhibitor for patients 18 years of age or older with moderate to severe atopic dermatitis.
A phase III trial investigating an oral JAK inhibitor for patients 18 years and older with moderate to severe atopic dermatitis.
Franklin BioScience protocol 001: An Observational Study on the Treatment of Eczematous Conditions with a Topical Cannabinoid Gel Designed to Improve the Appearance
of Affected Skin -CURRENTLY ENROLLING
A study investigating the use of a topical cannabinoid gel in adults 21 years of age and older with mild to moderate atopic dermatitis.